« Previous
Next »
European Journal of Internal Medicine
Volume 20, Issue 8
, Pages 775-778
, December 2009
Evaluation of in vivo antineoplastic effects of rapamycin in patients with chemotherapy-refractory AML
To access this article, please choose from the options below
☆ On behalf of all authors Peter Valent states no conflict of interest.
PII: S0953-6205(09)00184-8
doi: 10.1016/j.ejim.2009.09.007
© 2009 European Federation of Internal Medicine. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
European Journal of Internal Medicine
Volume 20, Issue 8
, Pages 775-778
, December 2009
